A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block
A Randomized Controlled Trial : Comparison of 4% Articaine Versus 0.5% Bupivacaine for Ambulatory Orthopaedic Surgery Under Supraclavicular Block
1 other identifier
interventional
60
1 country
1
Brief Summary
Effect of 2%Articaine versus 5%bupivacaine in pt undergoing short duration surgery in upper limb
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Dec 2019
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2019
CompletedFirst Posted
Study publicly available on registry
December 6, 2019
CompletedStudy Start
First participant enrolled
December 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2020
CompletedApril 28, 2020
April 1, 2020
3 months
December 3, 2019
April 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Duration of sensory block
By pinprick test from 0 to 2 where 0 no sensory block and 2 complete anesthesia
Measured in minutes over 24 hours
Durations of motor block
By Bromage scale from 1 to 4 where 1 no motor power and 4 full motor power
Measured in minutes over 24 hours
Duration of analgesia
Measured by numerical analog scale where 0 no pain and 10 means worst pain
Measured in minutes over 24 hours
Secondary Outcomes (1)
Analgesia
24 hours
Study Arms (2)
Articaine group
EXPERIMENTALPatients in this group are assigned to recieve 30 ml of Articaine 2%
Bupivacaine
EXPERIMENTALPatients in this group are assigned to recieve 30 ml of bupivacaine 0.5%
Interventions
Eligibility Criteria
You may qualify if:
- upper limb surgery
- ganglion removal
- k wiring
- Carapal tunnel
You may not qualify if:
- Coagulopathy.
- infection at site of injection.
- patient refusal.
- hypersensitivity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University hosptal
Cairo, Abbasya, Egypt
Related Publications (1)
Armanious SH, Abdelhameed GA. A Randomized Controlled Trial: Comparison of 4% Articaine versus 0.5% Bupivacaine for Ambulatory Orthopedic Surgery under Supraclavicular Block. Anesthesiol Res Pract. 2020 Sep 24;2020:2194873. doi: 10.1155/2020/2194873. eCollection 2020.
PMID: 33029135DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Galal Mo El kadi, Doctor
Professor
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 3, 2019
First Posted
December 6, 2019
Study Start
December 30, 2019
Primary Completion
March 22, 2020
Study Completion
March 27, 2020
Last Updated
April 28, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Within 6 month after end of study
- Access Criteria
- Upon request from Corresponding Author
All data including primary and secondary outcome for all the participants